Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.Richard Görlick, Barry Anderson, Neyssa Marina et al.|PubMed|2003Cited by 198
Retargeting T Cells to GD2 Pentasaccharide on Human Tumors Using Bispecific Humanized AntibodyHong Xu, Nai‐Kong V. Cheung, Ming Cheng et al.|Cancer Immunology Research|2014Cited by 97
GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcomaJeong A Park, Nai‐Kong V. Cheung|Journal of Hematology & Oncology|2020Cited by 86
Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodiesBrian H. Santich, Nai‐Kong V. Cheung, Jeong A Park et al.|Science Translational Medicine|2020Cited by 83
Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine releaseJeong A Park, Nai‐Kong V. Cheung|Journal for ImmunoTherapy of Cancer|2021Cited by 47